55.01
Schlusskurs vom Vortag:
$55.52
Offen:
$55.55
24-Stunden-Volumen:
147.01K
Relative Volume:
0.53
Marktkapitalisierung:
$2.23B
Einnahmen:
$1.46B
Nettoeinkommen (Verlust:
$92.09M
KGV:
24.39
EPS:
2.2555
Netto-Cashflow:
$47.29M
1W Leistung:
+2.92%
1M Leistung:
+14.59%
6M Leistung:
+45.30%
1J Leistung:
+186.14%
Phibro Animal Health Corp Stock (PAHC) Company Profile
Firmenname
Phibro Animal Health Corp
Sektor
Telefon
201-329-7300
Adresse
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC vs TAK, ZTS, HLN, TEVA, UTHR
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
PAHC
Phibro Animal Health Corp
|
54.91 | 2.25B | 1.46B | 92.09M | 47.29M | 2.2555 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.20 | 59.20B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
118.24 | 49.79B | 9.47B | 2.67B | 2.28B | 6.0218 |
|
HLN
Haleon Plc Adr
|
9.935 | 44.27B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
29.68 | 35.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
555.02 | 24.75B | 3.18B | 1.33B | 1.04B | 27.90 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-07 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2025-06-16 | Hochstufung | BNP Paribas Exane | Underperform → Neutral |
| 2024-09-10 | Eingeleitet | JP Morgan | Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Underperform |
| 2022-12-21 | Eingeleitet | ROTH Capital | Buy |
| 2022-07-25 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-10 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-07-07 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2020-08-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2020-02-06 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2020-01-28 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2019-09-05 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2019-08-29 | Bestätigt | BofA/Merrill | Underperform |
| 2019-06-11 | Eingeleitet | Barclays | Underweight |
| 2019-05-23 | Eingeleitet | Guggenheim | Neutral |
| 2019-05-09 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2017-08-23 | Fortgesetzt | BofA/Merrill | Underperform |
| 2017-06-02 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2016-12-15 | Eingeleitet | Piper Jaffray | Overweight |
| 2016-11-11 | Herabstufung | Macquarie | Neutral → Underperform |
| 2016-11-10 | Herabstufung | Gabelli & Co | Buy → Hold |
| 2016-04-11 | Bestätigt | Guggenheim | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2016-01-15 | Herabstufung | Barclays | Overweight → Underweight |
| 2015-09-30 | Eingeleitet | Gabelli & Co | Buy |
| 2015-04-24 | Bestätigt | Barclays | Overweight |
| 2015-04-21 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2014-05-06 | Eingeleitet | Barclays | Overweight |
Alle ansehen
Phibro Animal Health Corp Aktie (PAHC) Neueste Nachrichten
Phibro Animal Health Corporatio (PAHC) Stock forecasts - Yahoo Finance UK
Zacks Investment Ideas feature highlights Phibro, Deluxe, Remitly and BrightSpring - Yahoo Finance
Phibro Animal Health Corp-A (NASDAQ:PAHC) Passes Minervini's High-Growth Momentum Screen - ChartMill
BFI Co. sells $757k in Phibro Animal Health (PAHC) stock By Investing.com - Investing.com South Africa
BFI Co. sells $757k in Phibro Animal Health (PAHC) stock - investing.com
Bendheim-linked BFI Co. LLC (PAHC) sells 14,080 shares under 10b5-1 - Stock Titan
4 Small Cap Stocks with Outstanding Fundamentals and Momentum - TradingView
Evaluating Acadia Healthcare's Outlook: Hold for Now or Fold? - TradingView
Momentum Shift: How do insiders feel about Phibro Animal Health CorporationWeekly Trade Report & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Sentiment Recap: What is the long term forecast for Phibro Animal Health Corporation stockTrade Exit Summary & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Phibro Animal Health Stock Up 152.3% in a Year: What's Driving It? - Yahoo Finance
Phibro Animal Health Corp. Hits New 52-Week High of $57.62 - Markets Mojo
Vanguard disaggregates holdings; reports 0 PAHC shares (PAHC) - Stock Titan
BFI Co. sells Phibro Animal Health (PAHC) shares for $1.16 million - Investing.com
Phibro Animal Health (PAHC) insider entity BFI Co. sells 21,120 shares - Stock Titan
Reasons Behind Holding Humana Shares: What Investors Need to Know - TradingView
Phibro Animal Health stock hits all-time high at 56.86 USD - Investing.com
TerrAscend (OTCMKTS:TSNDF) and Phibro Animal Health (NASDAQ:PAHC) Head to Head Analysis - Defense World
Insider Selling: Phibro Animal Health (NASDAQ:PAHC) CEO Sells $272,764.80 in Stock - Defense World
Is It Too Late To Consider Phibro Animal Health (PAHC) After Its 143% One Year Surge? - Yahoo Finance
BFI Co sells Phibro Animal Health (PAHC) stock worth $1.19 million - Investing.com India
BFI Co sells Phibro Animal Health (PAHC) stock worth $1.19 million By Investing.com - Investing.com South Africa
Insider Selling: Phibro Animal Health (NASDAQ:PAHC) CEO Sells 10,560 Shares of Stock - MarketBeat
Phibro Animal Health (PAHC) CEO-linked BFI Co. sells 22,880 shares in Rule 10b5-1 trades - Stock Titan
Phibro Animal Health says Daniel Bendheim to assume CEO role in July - MSN
Volatility Watch: Is Phibro Animal Health Corporation gaining market shareOil Prices & Weekly Setup with ROI Potential - baoquankhu1.vn
Phibro Animal Health (PAHC) director Bendheim sells $258,244 in shares By Investing.com - Investing.com UK
Phibro Animal Health (PAHC) director Bendheim sells $258,244 in shares - Investing.com
BrightSpring Health Services, Collegium Pharmaceutical, and Phibro Animal Health Shares Are Soaring, What You Need To Know - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) CEO Jack Bendheim Sells 5,280 Shares - MarketBeat
BFI Co. tied to Phibro Animal Health (PAHC) converts and sells shares - Stock Titan
A Look At Phibro Animal Health (PAHC) Valuation After Recent Share Price Gains - Yahoo Finance
Phibro Animal Health (NASDAQ:PAHC) Upgraded at Zacks Research - Defense World
Multiple resale transactions by affiliate reported for Phibro Animal Health (PAHC) - Stock Titan
Zacks Research Upgrades Phibro Animal Health (NASDAQ:PAHC) to Strong-Buy - MarketBeat
Is PAHC Stock a Solid Investment Opportunity Right Now? - Yahoo Finance
Best Value Stocks to Buy for March 12th - Yahoo Finance
Looking for earnings beat? Buy these 4 top-ranked stocks - MSN
EPS Watch: Will Phibro Animal Health Corporation benefit from AI trends2026 Momentum Check & Verified Swing Trading Watchlists - baoquankhu1.vn
Is Community Health Systems Attractive Despite Its Heavy Debt Load? - TradingView
Is It Too Late To Consider Phibro Animal Health (PAHC) After 1-Year Share Price Surge? - simplywall.st
How risky is Phibro Animal Health Corporation stock nowJuly 2025 Breakouts & Daily Risk Controlled Trade Plans - Naître et grandir
Phibro Animal Health Corporation $PAHC Shares Sold by Vanguard Group Inc. - MarketBeat
How The Investment Story Is Shifting For Phibro Animal Health (PAHC) After Fresh Analyst Targets - Yahoo Finance
Here's Why Ensign Group Shares Are Attracting Investors Now - TradingView
Here's Why You Should Add DaVita Stock to Your Portfolio for Now - Finviz
PAHC Earnings History & Surprises | EPS & Revenue Results | PHIBRO ANIMAL HEALTH CORP-A (NASDAQ:PAHC) - ChartMill
Here's Why You Should Retain Clover Stock in Your Portfolio for Now - Finviz
How To YieldBoost PAHC To 15.4% Using Options - Nasdaq
Ex-Dividend Reminder: Phibro Animal Health, Pjt Partners and Equitable Holdings - Nasdaq
Phibro Animal Health Raises Guidance at BofA Conference as Zoetis MFA Integration Advances - Yahoo Finance
Finanzdaten der Phibro Animal Health Corp-Aktie (PAHC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Phibro Animal Health Corp-Aktie (PAHC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| BENDHEIM JACK | President and CEO |
Mar 30 '26 |
Sale |
53.61 |
7,040 |
377,406 |
45,160 |
| BENDHEIM JACK | President and CEO |
Mar 26 '26 |
Sale |
56.80 |
7,040 |
399,876 |
52,200 |
| BENDHEIM JACK | President and CEO |
Mar 25 '26 |
Sale |
55.91 |
7,040 |
393,606 |
59,240 |
| BENDHEIM JACK | President and CEO |
Mar 24 '26 |
Sale |
52.93 |
7,040 |
372,623 |
66,280 |
| BENDHEIM JACK | President and CEO |
Mar 18 '26 |
Sale |
52.68 |
10,560 |
556,330 |
80,360 |
| BENDHEIM JACK | President and CEO |
Mar 19 '26 |
Sale |
52.52 |
7,040 |
369,729 |
73,320 |
| BENDHEIM JACK | President and CEO |
Mar 17 '26 |
Sale |
51.66 |
5,280 |
272,760 |
90,920 |
| BENDHEIM JACK | President and CEO |
Mar 13 '26 |
Sale |
48.91 |
5,280 |
258,245 |
96,200 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):